Author Question: Dickerson Corporation's common stock is currently selling for 38. Last year's dividend was 4.00 per ... (Read 68 times)

abc

  • Hero Member
  • *****
  • Posts: 543
Dickerson Corporation's common stock is currently selling for 38. Last year's dividend was 4.00 per share.
  Investors expect dividends to grow at an annual rate of 7 percent indefinitely.
 
  Flotation costs of 4 will be
  incurred when new stock is sold.
  a. What is the cost of internal common equity?
  b. What is the cost of new common equity?

Question 2

Kinard's Kennels Inc ROE is 20. Their dividend payout ratio is 70. The last dividend, just paid,
  was 2.00.
 
  If dividends are expected to grow by the company's internal growth rate indefinitely,
  what is the current value of Kinard's common stock if its required return is 18?
  A) 14.92 B) 17.67 C) 16.89 D) 11.52


Li Jun

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

a. D1 = 4.00  1.07 = 4.28
Cost of internal common equity = 4.28/38 + .07 = 18.26
b. Cost of new common equity = 4.28/(38  .

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library